BALAJI AMINES LTD.-$
P&L
Quarterly Consolidated
vs Q4 FY25
Balaji Amines Q1FY26 Revenue at ₹ 367 Crore; EBITDA at ₹ 64 Crore; Net Profit at ₹ 31 Crore
02 Aug 2025 · 2 Aug 2025, 10:01 pm
Summary
Balaji Amines Limited, a leading manufacturer of Aliphatic Amines & Speciality Chemicals in India, announced its unaudited financial results for the quarter ended June 30, 2025. The company reported a consolidated Q1FY26 revenue of ₹ 367 Crore, EBITDA of ₹ 64 Crore, and a net profit of ₹ 31 Crore. The company is investing in new projects and expanding its capacities, with a focus on driving sustainable progress and operational excellence.
Key Highlights
- 1
Revenue from Operations for Q1FY26 stood at ₹ 367 crore
- 2
EBITDA for Q1FY26 was ₹ 64 crore
- 3
PAT for Q1FY26 was ₹ 31 crore
- 4
Total volumes stood at 27,570 MT for Q1FY26
- 5
New projects for Dimethyl Ether (DME), N-Methyl Morpholine (NMM), and Acetonitrile are under execution
- 6
Investment of Rs. 750 crs in Balaji Speciality Chemicals Limited for wide range of products
- 7
Unit- 1 Brown field project for EDA based products is progressing as per the plan
- 8
Unit - 2 Greenfield Project for setting up of HCN, NaCn, EDTA plants at MIDC Chincholi are progressing as per the plan
Management Comments
Mr. D. Ram Reddy
Managing Director
During Q1 FY26, our financial and business performance remained stable, supported by a disciplined working model with stable commodity prices. As volume uptake gradually improves, we anticipate EBITDA and PAT margins to expand, in line with the industry recovery. With the present global and domestic scenario, the utilization of expanded capacities may be impacted in the coming quarters until the basic contribution for our products come through. At BAL, we remain focused on driving sustainable progress, backed by ongoing investments in key projects and our commitment to operational excellence.
Informational and educational content only. Not investment advice.